Michigan Institute for Neurological Disorders

04/10/2026

A shift in Alzheimer’s care is underway.

New research highlighted in MedPage Today suggests the future of Alzheimer’s may focus on detecting the disease years before symptoms appear—using biomarkers, digital cognitive assessments, and emerging therapies.

Experts note that Alzheimer’s is increasingly being understood as a biological process that begins long before memory loss, creating new opportunities for earlier evaluation and intervention, but also raising important questions around diagnosis, decision-making, and patient support.

At the Michigan Institute for Neurological Disorders (MIND), our Alzheimer’s Disease & Memory Disorders Center is aligned with this evolving approach, providing comprehensive evaluations, advanced diagnostics, and thoughtful, patient-centered care to guide individuals and families through every stage of the disease.

Read more: https://bit.ly/40zQJDH

Research roundtable highlights early detection, biomarkers, interventions

04/09/2026

MIND continues to contribute to a national collaboration of leading neurology practices through NeuroDiscovery AI, working together to advance research and improve care for complex neurological diseases.

Dr. Martin Belkin, Medical Director of MIND’s MS Center, serves as a committee member on the NeuroDiscovery AI MS Advisory Committee, helping guide research initiatives focused on improving care for people living with multiple sclerosis.

Dr. Jonathan Fellows, Medical Director of MIND’s Alzheimer’s Disease & Memory Disorders Center, serves as a committee member on the Alzheimer’s Subcommittee, contributing clinical insight to initiatives focused on advancing research and improving care for patients living with Alzheimer’s disease and related dementias.

MIND CEO Dan Badgley also participates on the organization’s Operations Advisory Committee, contributing to discussions on how emerging technologies can responsibly support neurological research and patient care.

The collaboration supports research initiatives and clinical insights that may help identify trends in neurological disease and expand opportunities for clinical trials.

Learn more: https://bit.ly/3O4aZdY

04/08/2026

Individuals living with MS and their care partners are invited to attend the 2026 Holistic Health & Wellness Forum for MS, presented by Yoga Moves Any Body.

Through presentations from national MS experts, attendees will gain a broader understanding of a whole-systems approach to wellness. Session topics will explore strategies that support the whole person—mind, body, and spirit—helping individuals with MS take an active role in supporting their health and well-being.

Dr. Martin Belkin, Medical Director of the MIND Multiple Sclerosis Center, will also be among the featured speakers participating in the program.

Tuesday, April 21, 2026
The MINT – Michigan First Conference Center
27000 Evergreen, Lathrup Village, MI
4:00 PM (EST) – Exhibit Hall & Registration Opens
5:00 PM (EST) – Program Begins

Following the presentations, attendees will have the opportunity to participate in an interactive breakout-style session to observe demonstrations and ask questions.

Dinner is provided.

This is a complimentary event. Donations are appreciated ($35 suggested). Register at: https://yogamovesanybody.org/events/2026-holistic-health-and-wellness-forum-for-ms/

04/07/2026

New research suggests that combining two blood biomarkers may improve how Alzheimer’s disease is identified—helping increase accuracy while reducing false positives.

In one study, this combined approach identified Alzheimer’s disease with 81% accuracy, while also helping distinguish between early biological changes and disease more likely to be contributing to symptoms.

As new treatments emerge, understanding not just if Alzheimer’s-related changes are present—but whether they’re driving symptoms—will be critical to making informed care decisions.
“These biomarkers are helping us better understand Alzheimer’s disease,” said Dr. Jonathan Fellows, Medical Director of MIND’s Alzheimer’s Disease & Memory Disorders Center. “But diagnosis still depends on how those findings relate to a patient’s symptoms and overall clinical picture.”

Read more from MedPage Today: https://bit.ly/41FXzb4

Dual biomarkers improve accuracy, reduce false positives

04/06/2026

More voices. More stories. More reflections from patients who trust MIND with their neurological care.

Thank you for allowing us to be part of your journey.

04/05/2026

Wishing our patients, families, and community an “egg-cellent” Easter.

04/02/2026

When people think of Parkinson’s disease, tremors are often the first thing that comes to mind.

But Parkinson’s can also show up in less visible ways, like changes in sleep, mood, balance, handwriting, or even sense of smell.

Because symptoms can vary from person to person, diagnosis isn’t always straightforward, and care shouldn’t be one-size-fits-all.

At MIND, our approach focuses on understanding the full picture, so care plans reflect each patient’s specific symptoms, progression, and goals.

April is Parkinson’s Awareness Month—a reminder that awareness starts with looking beyond the obvious.

At the MIND Parkinson’s Disease & Movement Disorders Center, we provide comprehensive, specialized care tailored to every stage of Parkinson’s: https://bit.ly/4s0Z8uY

04/01/2026

Happy Passover from all of us at MIND! Wishing a peaceful and meaningful Passover to all who celebrate.

May this time bring strength, hope, and togetherness.

03/31/2026

The way we treat multiple sclerosis is changing—and for the better.

In a recent Healio Q&A, MIND neurologist and fellowship-trained MS specialist Dr. Jonathan Doty shares how earlier diagnosis, more advanced therapies, and personalized treatment strategies are reshaping MS care.

Today, with more than 20 treatment options available, care is no longer one-size-fits-all. It’s about acting earlier, tailoring treatment, and surrounding patients with the right team from the start.

Integrated care—bringing together neurology, diagnostics, and infusion services—also plays a critical role in helping patients stay ahead of disease progression. At MIND, this comprehensive approach is how we support patients at every stage of their journey.

Read more in Healio: https://bit.ly/4m0P0kM

Advances in diagnostics and disease-modifying therapies have significantly expanded treatment options for MS over the past 2 decades. With more than 20 FDA-approved therapies now available, clinicians face increasingly complex decisions about when to initiate treatment, how to monitor disease activi...

03/30/2026

Today, we recognize the physicians who lead care across MIND—bringing expertise, precision, and compassion to those they serve.

From neurologists to neuroradiologists and other physician specialists, their work is essential in diagnosing complex conditions, guiding treatment decisions, and supporting individuals throughout each stage of the care journey.

At MIND, this physician-led expertise is part of a coordinated approach that delivers comprehensive neurological services—all in one place.

On National Doctor’s Day, we thank our physicians for the expertise, dedication, and compassion they bring to those who rely on them.

03/30/2026

If you or someone you care for is navigating multiple sclerosis, knowing what to expect—and where to go for specialized care—can make a difference.

We’ve updated the MIND Multiple Sclerosis Center page to better assist patients, caregivers, and referring providers throughout every stage of the MS journey.

From initial symptoms and diagnosis to treatment and long-term care, the page showcases MIND’s comprehensive, coordinated approach—led by fellowship-trained MS specialists and supported by advanced imaging, infusion therapy, and continuous monitoring.

Explore topics including:
• When to see an MS specialist
• What to expect during evaluation
• Treatment and long-term care
• FAQs and patient resources

https://mindonline.com/multiple-sclerosis-center/

03/28/2026

MIND Multiple Sclerosis Center Director Dr. Martin Belkin recently joined joined Tracey McCaskill on WWJ Newsradio 950's Voices of the Community to discuss how advances in diagnosis and treatment are helping patients live fuller, more active lives.

“Earlier diagnosis is changing what’s possible in MS care,” said Belkin. "Today, we have more options than ever to manage symptoms."

Hear the full conversation: https://bit.ly/4tdNw97